CCAAT/Enhancer Binding Protein β inhibits myogenic differentiation via ID3

Hamood AlSudais1, Neena Lala-Tabbert2, Nadine Wiper-Bergeron3

  • 1Graduate Program in Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, 451 Smyth Road, Ottawa, Ontario, K1H 8M5, Canada.

Scientific Reports
|November 11, 2018
PubMed

Insights

CCAAT/Enhancer Binding protein beta (C/EBPβ) inhibits muscle development by increasing Id3 expression. Loss of Id3 rescues myogenic differentiation, revealing a key mechanism in muscle precursor cell regulation.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Developmental Biology

Background:

  • Myogenesis, or muscle development, relies on muscle regulatory factors (MRFs) like MYOD and myogenin.
  • Inhibitor of DNA binding (ID) proteins can block MRF activity by binding E proteins.
  • CCAAT/Enhancer Binding protein beta (C/EBPβ) inhibits muscle differentiation, but its mechanism is unclear.

Purpose of the Study:

  • To elucidate the mechanism by which C/EBPβ inhibits myogenic differentiation.
  • To identify novel target genes of C/EBPβ involved in muscle development.

Main Methods:

  • Overexpression of C/EBPβ in myogenic precursors.
  • Analysis of Id3 mRNA and protein expression.
  • Assessment of myogenic differentiation markers.
  • Genetic manipulation to rescue differentiation in C/EBPβ-misexpressing cells.

Main Results:

  • C/EBPβ directly stimulates Id3 gene and protein expression.
  • Id3 is essential for C/EBPβ-mediated inhibition of myogenic differentiation.
  • Loss of Id3 function rescues muscle differentiation in models with C/EBPβ misexpression, such as cancer cachexia.

Conclusions:

  • Id3 is a novel target gene of C/EBPβ.
  • C/EBPβ inhibits myogenic differentiation primarily by inducing Id3 expression.
  • This C/EBPβ-Id3 pathway is a critical regulator of muscle precursor cell fate.

Related Concept Videos

Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.1K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.6K
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
559
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.1K
RNA Polymerase II Accessory Proteins02:36

RNA Polymerase II Accessory Proteins

Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
11.0K
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
8.8K